Our Product Pipeline

Botanix’s product pipeline includes three advanced clinical programs which are leveraging synthetic cannabidiol in the topical treatment of serious skin diseases and for antimicrobial applications. Botanix also has an active discovery chemistry program to identify, synthesise, and test novel chemical entities that are structurally related to naturally occurring cannabinoids. In addition, Botanix has an exclusive license to use a proprietary drug delivery system called Permetrex, for direct skin delivery of pharmaceuticals.

Product Indication Phase 1 Phase 1b Phase 2 Phase 3 Status
BTX 1503 Gel Moderate to severe acne
Successful End of Phase 2 Meeting with FDA
BTX 1702 Solution Rosacea
Phase 1b study
BTX 1801 Ointment Antimicrobial
Phase 2a study